AGNC vs EQIX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AGNC exhibits severe financial health concerns, as evidenced by a Piotroski F-Score of 3/9 (indicating weak fundamentals) and a missing Altman Z-Score, which raises unquantified distress risk. Despite a high intrinsic value estimate of $43.37 and a Graham Number of $17.64, the stock trades at $10.23, suggesting a potential undervaluation—however, this is undermined by extreme leverage (Debt/Equity: 6.89), near-zero liquidity (Current Ratio: 0.18), and a 97.96% payout ratio. The recent insider selling of $11.43M over six months signals strong bearish sentiment, while earnings have consistently missed expectations in the last four quarters. The 52-week range of $7.85–$12.19 reflects high volatility and lack of sustained momentum.
EQIX shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
AGNC vs EQIX: Head-to-Head Comparison
This page compares AGNC Investment Corp. (AGNC) and Equinix, Inc. (EQIX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.